Omegin Dr.Schmidgall GmbH (3085072) - תוצאות חיפוש

tzamal bio-pharma ltd - calcitonin salmon 200 iu/dose - nasal spray - calcitonin (salmon synthetic) - fortical® nasal spray is indicated for:postmenopausal osteoporosis – fortical® calcitonin-salmon (rdna origin) nasal spray isindicated for the treatment of postmenopausal osteoporosis in women greater than 5 yearspostmenopause with low bone mass relative to healthy premenopausal women. use of fortical®calcitonin-salmon (rdna origin) nasal spray is recommended in conjunction with an adequatecalcium (at least 1000 mg elemental calcium per day) and vitamin d (400 international units perday) intake to retard the progressive loss of bone mass. the evidence of efficacy for calcitoninsalmonis based on increases in spinal bone mineral density (bmd) observed in clinical trials

ישראל - עברית - Ministry of Health

סנדאימון ניאורל 50 מג כמוסות

novartis israel ltd - ciclosporin - קפסולות - ciclosporin 50 mg - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.

ישראל - עברית - Ministry of Health

סנדאימון ניאורל 100 מג כמוסות

novartis israel ltd - ciclosporin - קפסולות - ciclosporin 100 mg - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.

ישראל - עברית - Ministry of Health

פילינג גוף-דר אולנג'ין

אינטרקוסמא (1985) בעמ - רחצת הגוף